ENTA icon

Enanta Pharmaceuticals
ENTA

Overview Fund Activity

151 hedge funds and large institutions have $811M invested in Enanta Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 57 increasing their positions, 60 reducing their positions, and 30 closing their positions.

Holders
151
Holders Change
-21
Holders Change %
-12.21%
% of All Funds
2.68%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
9
Increased
57
Reduced
60
Closed
30
Calls
$58K
Puts
$3.57M
Net Calls
-$3.51M
Net Calls Change
-$1.37M

Top Buyers

1
AC
1
Armistice Capital
New York
$57.1M
2
State Street
2
State Street
Massachusetts
$49.4M
3
BlackRock
3
BlackRock
New York
$143M
4
CS
4
Candriam SCA
Luxembourg
$7.53M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$75.8M

Top Sellers

1
Ameriprise
1
Ameriprise
Minnesota
$4.67M
2
Goldman Sachs
2
Goldman Sachs
New York
$6.8M
3
Assenagon Asset Management
3
Assenagon Asset Management
Luxembourg
$0
4
First Manhattan
4
First Manhattan
New York
$10M
5
Man Group
5
Man Group
United Kingdom
$7.46M
Name Holding Trade Value Shares
Change 		Shares
Change %
IA
176
IFP Advisors
Florida
– -$11K -259 Closed
PCM
177
Prelude Capital Management
New York
– -$11K -245 Closed
SFS
178
Sowell Financial Services
Arkansas
– -$2K -40 Closed
4 5 6 7
8